An Analysis of the Bibliography Card

¶ … Card Chen, X., Huang, R., Huang, Q., Chu, Y., and Yao, J. (2015). Systemic Review and Meta-Analysis of the Clinical Efficacy and Adverse Effects of ZhengqingFengtongning Combined with Methotrexate in Rheumatoid Arthritis. Evidence-Based Complementary and Alternative Medicine Volume 2015. By definition, Rheumatoid arthritis (RA) is a protracted general inflammatory ailment, categorized by infammation of the synovial soft tissue and mutilation to articular tendons and bone, which in turn brings about extreme incapacity, practical deterioration, and enhanced death.

This ailment is the most prevalent one with rheumatism having a pervasiveness of about one percent in North America and Europe, while that of Southeast Asia is lower to some extent as it has about 0.3%. The disease is an area of major concern as it is estimated that at the present moment, about five million individuals suffer from rheumatoid arthritis. This in turn has come to be both a social and economic problem as the disease enforces a substantial encumbrance on the patients, their households, and society as a whole.

Some of the options for treatment of the disease include anti-infammatory drugs. These are (NSAIDs), which can be obtained from a variety of stores. As well, there are "Disease Modifying Anti-Rheumatic Drugs" (DMARDs). Methotrexate (MTX) is one of the latter set of drugs, and is considered to be among the first product line drugs that treat rheumatoid arthritis. It is considered that these approaches of treatment do not have any adverse impacts on the patients such as retardation or even hindering progress in radiation.

There are strong suits of the study which are commendable. To start with, the set of participants are those who use ZQFTN (ZhengqingFengtongning) together with MTX in contrast to the participants who employed MTX only. This is important, as it is possible to show the efficacy and safety of the combination of the two drugs. In addition, the study did not include any conflict of interests. More so, in the literature, any duplicates that arose were not included.

I am in agreement with the authors in the selection of the methodology to be applied in the study. The use of randomized controlled trials is pertinent with such a case as it is with other different medical studies. The authors ensured that the participants in the study had taken ZQFTN in addition with MTX. This was contrasted with the other set of participants who has taken MTX only. In addition, the authors and researchers of the study took careful measures.

They made certain that all of the participants were actual patients who had a clear understanding of the diagnosis of RA. What is more, the principles and standards for diagnosis for RA in the medical and clinical trials were conducted in accordance with American Rheumatism Association. Being taken into consideration, it was pertinent that the researchers make use of ZQFTN as the active treatment for intervention. One of.